Orianesth SRL
Orianesth reported total assets of 813,606 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Orianesth shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +82 % Total assets +93 %
Accounts of the company itself (not consolidated).
The full file covers 14 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Orianesth's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 115,132 € | ||||
| Equity | 360,806 € | ||||
| Cash | 95,700 € | ||||
| EBITDA | 286,850 € | ||||
| Total assets | 813,606 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 09 Oct 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Orianesth's financial analysis
- Solvency44.3%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Orianesth
Orianesth's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.176.184
- VAT number
- BE0474176184
- Peppol
- Registered · 0208:0474176184 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Feb 2001
- Registered office
- 6210 Les Bons Villers
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Orianesth (SRL) has been based in Les Bons Villers since 2001, active in: medical specialists activities. For 2025, it reports a net profit of 115,132 € and equity of 360,806 €; its revenue is not published. Its solvency stands at 44.3%, below the median of its sector (65.0%).
Companies similar to Orianesth
Companies in the same business, of comparable size and area, outside its group.
- Cabinet D'Expertise Radiologiques D'Avister Medical specialists activities Esneux · balance sheet 814,024 €
- Dokter Rupal Mehta Medical specialists activities Sint-Pieters-Leeuw · balance sheet 814,150 €
- Hariba Medical specialists activities Uccle · balance sheet 814,563 €
- GynCARE Docteurs F. Closon et S. Verscheure Medical specialists activities Anthisnes · balance sheet 812,545 €
- Medoculus Medical specialists activities Edegem · balance sheet 812,501 €
- DR. ANN Vantrappen Medical specialists activities Leuven · balance sheet 814,938 €
- Dr. Mies Crivits – Anesthesie Medical specialists activities Ghent · balance sheet 812,069 €
- DR. Peter Coeman - Orthopedie-Traumatologie Medical specialists activities Zulte · balance sheet 811,692 €
Frequently asked questions about Orianesth
What is the revenue of Orianesth?
Orianesth files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Orianesth?
In Belgium, the VAT number is the company number prefixed with BE: BE0474176184 for Orianesth, if the company is VAT-registered. Its company number (CBE) is 0474.176.184.
Where is the registered office of Orianesth?
According to the CBE register, the registered office of Orianesth is in 6210 Les Bons Villers.
What is the equity of Orianesth?
At the close of the 2025 financial year, the equity of Orianesth amounts to 360,806 €, a solvency of 44.3% of total assets.
Who manages Orianesth?
The register lists 2 active mandates at Orianesth. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Orianesth
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →